Details for New Drug Application (NDA): 021087

✉ Email this page to a colleague

NDA 021087 describes TAMIFLU, which is a drug marketed by Roche and is included in two NDAs. It is available from three suppliers. Additional details are available on the TAMIFLU profile page.

The generic ingredient in TAMIFLU is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.

Summary for 021087

Tradename:	TAMIFLU
Applicant:	Roche
Ingredient:	oseltamivir phosphate
Patents:	0

Pharmacology for NDA: 021087

Mechanism of Action	Neuraminidase Inhibitors

Medical Subject Heading (MeSH) Categories for 021087

Antiviral Agents
Enzyme Inhibitors

Suppliers and Packaging for NDA: 021087

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TAMIFLU	oseltamivir phosphate	CAPSULE;ORAL	021087	NDA	Genentech, Inc.	0004-0800	0004-0800-07	1 BOTTLE, PLASTIC in 1 CARTON (0004-0800-07) / 10 CAPSULE in 1 BOTTLE, PLASTIC
TAMIFLU	oseltamivir phosphate	CAPSULE;ORAL	021087	NDA	Genentech, Inc.	0004-0800	0004-0800-08	1 BOTTLE, PLASTIC in 1 CARTON (0004-0800-08) / 10 CAPSULE in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 75MG BASE
Approval Date:	Oct 27, 1999	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 45MG BASE
Approval Date:	Jul 2, 2007	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 30MG BASE
Approval Date:	Jul 2, 2007	TE:	AB	RLD:	Yes

Expired US Patents for NDA 021087

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Roche	TAMIFLU	oseltamivir phosphate	CAPSULE;ORAL	021087-002	Jul 2, 2007	⤷ Subscribe	⤷ Subscribe
Roche	TAMIFLU	oseltamivir phosphate	CAPSULE;ORAL	021087-001	Oct 27, 1999	⤷ Subscribe	⤷ Subscribe
Roche	TAMIFLU	oseltamivir phosphate	CAPSULE;ORAL	021087-003	Jul 2, 2007	⤷ Subscribe	⤷ Subscribe
Roche	TAMIFLU	oseltamivir phosphate	CAPSULE;ORAL	021087-001	Oct 27, 1999	⤷ Subscribe	⤷ Subscribe
Roche	TAMIFLU	oseltamivir phosphate	CAPSULE;ORAL	021087-002	Jul 2, 2007	⤷ Subscribe	⤷ Subscribe
Roche	TAMIFLU	oseltamivir phosphate	CAPSULE;ORAL	021087-002	Jul 2, 2007	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.